Knowledge Center
We believe in sharing knowledge being a key to success.
In this section you will find published articles and essays authored by members of the team of ten23 health.
2025 April - Predictions for Pharma's future, read Hanns-Christian's answer about the disruptions in 5-10 years in the pharmaceutical industry.
2025 April - A personal interview with our CEO Hanns-Christian Mahler in the Investment Reports of the Newsweek.
2025 March - CDMOs like ten23 health are adopting sustainable practices by utilising single-use bioreactors, continuous flow manufacturing, and biocatalysis to reduce waste and enhance efficiency.
2025 January - In this article, Anna Ruppl, Denis Kiesewetter, Monika Köll-Weber, Thomas Lemazurier, Regine Süss and Andrea Allmendinger elaborate about Lipid nanoparticles (LNPs) that have demonstrated their therapeutic potential as safe and effective drug delivery systems for nucleic acids during the COVID-19 pandemic.
2025 January - In this article, Andrea Allmendinger, PhD, Chief Scientific Officer,Dr. Nicolas Brandes and Hanns-Christian Mahler, PhD, Chief Enablement Officer, all at ten23 health discuss the device selection: Injection volumes for subcutaneous administration.
2024, September - In this article, Andrea Allmendinger, PhD, Chief Scientific Officer, Michael Adler, PhD, Director Drug Product Design, Carole Delauney, Senior Director Business Development, and Hanns-Christian Mahler, PhD, Chief Enablement Officer, all at ten23 health, provide an overview of large-volume wearable injection devices for the subcutaneous delivery of biologics and discuss the technical challenges associated with the development and manufacturing of these drug/device combination products.
2024, June - ten23 health: Leveraging Technology & Humans to Balance Development – Page 50 of Special Issue in Outsourcing Companies.
2024, May - In this article, Alissa Monk, Fairstainability Co-Circle Lead at ten23 health, Kami Krista, Chief Executive Officer and Co-Founder of Elio, Cédric Montagne, Sustainability Strategy, Reporting and Engagement, and Carole Schanté, PhD, Fairstainability Co-Lead, both of ten23 health, explore the potential of artificial intelligence and big data in eco-design with the aim of transforming the pharmaceutical industry towards greater sustainability.
2024, May - Michael Adler, Venkata Appa Reddy Goli, Andrea Allmendinger and Hanns-Christian Mahler, discuss the various factors that need to be considered when transferring to a delivery device for subcutaneous injection, such as a prefilled syringe or autoinjector, during clinical trials or post launch, especially when transferring from a vial format for intravenous infusion. Pages 08 to 14.
2024, March - Andrea Allmendinger, Philipp Behrendt and Hanns-Christian Mahler present the challenges of filling very small volumes into syringes for intravitreal injections, and how ten23’s innovative filling technology can help combat the critical issue of air bubble formation.
2024, February - Andrea Allmendinger and Hanns-Christian Mahler present two case studies to illustrate the complexity of modern sterile product developments.
2024, February - Europe's Pioneering Leaders Shaping the Future of Healthcare. In this article, Euro Health Leaders Magazine features a portrait of ten23 health's CEO & Founder Prof. Dr. Hanns-Christian Mahler.
2024, February - ten23 health: Sustainable success. With a dual mission to serve both patients and the planet, the Switzerland-based CDMO takes on today’s most complex sterile medicines.
2023, May - Intravitreal Injections - more than meets the eye: In this article, Andrea Allmendinger and Hanns-Christian Mahler highlight the technical challenges of intravitreal administration and considerations from the ophthalmologist’s and patient’s perspectives.
2023, March - Integrated Drug Product - Development and Manufacturing. Here, Andrea Allmendinger, Michael Adler and Hanns-Christian Mahler, all at ten23 health, highlight the importance of integrated drug product development, considering aspects such as formulation, device, container closure system, manufacturing processes and usability.
2023, February - Andrea Allmendinger and Hanns-Christian Mahler, talking about challenges in the commercialization of pre-filled syringes and injection devices.
2022 - Andrea Allmendinger and Hanns-Christian Mahler, talking about “How ten23 health is meeting developmental challenges for intravitreal products”.
2022, June - Hanns-Christian Mahler and Rainer Glöckler are talking about “Automating Aseptic Processing reduces Contamination Risk” in Pharmaceutical Technology.
2022, May - Susanne Jörg, our COO is talking about the relevance of Drug Product development and manufacturing for Biologics.
2022, April - Addressing the Challenges of Developing Large Volume Drug/Device Combination Products for Parenteral SC Delivery.
2021, April - On “State-of-the-art solutions for ophthalmic sterile drug product manufacturing” with Rainer Glöckler and Carole Delauney.
Brochures / Reports
Download the 2023 Fairstainability Report
Download the 2022 Fairstainability Report
Download the 2021 Fairstainability Report
Podcasts
2025. February: Listen to Kymanox Executive Advisor, Mathias Romacker, for an insightful conversation with industry pioneer Hanns-Christian Mahler, our Founder and CEO , as they explore the evolution of biologics drug delivery and CDMO services. From prefilled syringes to large-volume subcutaneous administration, discover how ten23 health is revolutionizing sterile fill-finish capabilities and combination product development.
2024. December: Hanns-Christian Mahler, Chief Enablement Officer at ten23 health, is redefining leadership in pharmaceutical manufacturing: “I believe collaboration at the workplace should be primarily based on trust and motivation, not on typical carrot and stick command and control models.
2024, October: We are happy to be featured in the latest CPHI issue by Pharmaceutical Technology, where we had the opportunity to discuss the fill/finish market and sustainability considerations for facilities. Listen to the podcast interview conducted by Felicity Thomas with our CEO Hanns-Christian Mahler.
2024, September: Listen to the interview in the Brightroom Podcast with Hanns-Chrsitian Mahler and Felicia Werk on how it is to work at ten23 and our company culture.
2024, June: Tune in to learn with our CEO Hanns-Christian Mahler on the current growth and advancements in pharmaceutical Fill/Finish, with a re-freshing interview conducted by Felicity Thomas.
2024, May: Listen to the first radio interview of Hanns-Christian Mahler in celebration of the World Laboratory Day in 2024, broadcasted through 175 radio stations in the United Kingdom!
2024, March: In this episode, Lori-Ann Duguay interviews Hanns-Christian Mahler, CEO of ten23 Health, about their unique approach to organizational culture.
2023, October: Hanns-Christian Mahler (CEO ten23 health) interviewed by Uwe Techt, in his podcast series 'Leverage Business! Das nachhaltig wachsende Unternehmen in Mittelstand' - German only
2023, May: Hanns-Christian Mahler (CEO ten23 health) and Andrea Allmendinger (CSO ten23 health) talk about Biologic Drug Development and Manufacturing on this episode of Drug Solutions Podcast.
2022, February: Hanns-Christian Mahler talking with Raman Seghal in the Molecule to Market podcast